Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00399633
Status:
COMPLETED
Last Update Posted:
2008-05-14
First Post:
2006-11-14
Brief Title:
Neuropeptides in the Humane Intra- og Extracerebral Circulation
Sponsor:
Danish Headache Center
Organization:
Danish Headache Center
Study Overview
Official Title:
Neuropeptides in the Humane Intra- og Extracerebral Circulation - in Relation to Sumatriptan in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aim at examining whether Sumatriptan changes the plasma values of the neuropeptides vasoactive intestinal polypeptide VIP calcitonin gene-related peptide CGRP and pituitary adenylate cyclase activating peptide PACAP and the prostanoids 6-keto-PGF1α and PGE2 PGD2 og PGF2α
Detailed Description:
The study is meant to give a better understanding of the basic mechanisms behind migraine and a better understanding of the effects of sumatriptan on the trigemino vascular system
The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal polypeptide VIP calcitonin gene-related peptide CGRP and pituitary adenylate cyclase activating peptide PACAP and the prostanoids 6-keto-PGF1α and PGE2 PGD2 og PGF2α
The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal polypeptide VIP calcitonin gene-related peptide CGRP and pituitary adenylate cyclase activating peptide PACAP and the prostanoids 6-keto-PGF1α and PGE2 PGD2 og PGF2α
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None